Wilson Sonsini Goodrich & Rosati is advising Rover Group, Inc. on the transaction, and Kirkland & Ellis is advising private equity funds managed by Blackstone. Blackstone...
Blackstone’s $2.3 Billion Acquisition of Rover
Cloud Light Technology’s $750 Million Acquisition of Lumentum
Morgan, Lewis & Bockius is advising Cloud Light Technology Limited on the transaction, and Wilson Sonsini Goodrich & Rosati is advising Lumentum Holdings Inc. Hong Kong–based...
Cyclo Therapeutics’ Acquisition of Applied Molecular Transport
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
Cadence’s Acquisition of Rambus PHY IP Assets
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
Novartis’ Acquisition of DTx Pharma
Wilson Sonsini Goodrich & Rosati is advising DTx Pharma on the transaction. A preclinical-stage biotechnology company, DTx Pharma announced that it has been acquired by Novartis. In addition...
Applied Intuition, Inc.’s Acquisition of Embark Technology, Inc.
Wilson Sonsini advised Embark Technology on the transaction, while Goodwin Procter advised Applied Intuition. Applied Intuition, Inc., a tooling and software provider for autonomous vehicle development,...
Pyxis Oncology’s Acquisition of Apexigen
Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...
Gilead’s Acquisition of XinThera
Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction. Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition...
Amphastar’s $1.075 Billion Acquisition of BAQSIMI from Eli Lilly
Wilson, Sonsini is acting as legal counsel to Amphastar. Kirkland & Ellis and Covington & Burling are acting as legal counsel to Lilly. In an effort...
Enliven Therapeutics’ Merger with Imara
Wilson Sonsini advised Enliven Therapeutics on the deal. Enliven Therapeutics, a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase...
Equillium’s Acquisition of Metacrine
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
Misfits Market’s Acquisition of Imperfect Foods
Wilson Sonsini advised Misfits Market on the deal. Misfits Market, the online grocery platform driven by accessibility, affordability, and sustainability, announced the acquisition of online grocer...